Ionis Pharma's rare metabolic disorder drug succeeds key study

(Reuters) - Ionis Pharmaceuticals Inc said on Monday its metabolic disorder drug for severe hypertriglyceridemia, characterized by elevated levels of a type of fat in the blood, met the main goal in a late-stage study.